Mehdi H. Shishehbor


Harrington Heart & Vascular Institute, University Hospitals Health System | President

Mehdi H. Shishehbor, DO, MPH, Ph.D. was appointed president of University Hospitals Harrington Heart & Vascular Institute in October 2020. Before his appointment, he joined University Hospitals Harrington HVI in August of 2017 as Co-Chair of the Clinical Executive Committee, Director of the Cardiovascular Interventional Center, and Co-Director of the Vascular Center. Before joining UH, Dr. Shishehbor directed the Endovascular Program at the Cleveland Clinic from 2009 to May 2017 and trained over 40 Interventional fellows and 400 physicians nationally on advanced techniques for limb salvage. In addition to his leadership roles, Dr. Shishehbor is an internationally known interventional cardiologist with expertise in vascular medicine and minimally invasive procedures to treat coronary, carotid, peripheral, and venous diseases. He is an expert in minimally invasive approaches to reconstructing lower extremity arteries to treat critical limb ischemia (CLI) and prevent amputation. Dr. Shishehbor is widely published on cardiovascular epidemiology, interventional cardiology outcomes, and techniques in leading journals such as the Journal of American Medical Association, New England Journal of Medicine, and Journal of the American College of Cardiology and Circulation. He is the author of several editorials, and textbook chapters, a co-author of a book on coronary intensive care and cardiac catheterization, and a manuscript reviewer for several prestigious medical publications.Dr. Shishehbor’s research interests include clinical outcomes in interventional cardiology, and carotid and endovascular interventions. He has a special interest in novel minimally invasive percutaneous approaches to treat cardiac, venous, and arterial diseases and has worked with several startup companies and early-stage devices. Additionally, he has served and is currently serving as the national principal investigator (PI) of multiple randomized trials related to vascular disease. Dr. Shishehbor is the Angela and James Hambrick Chair in Innovation and was recognized by University Hospitals in 2020 as a Distinguished Physician for his commitment to patient care. In 2018, Dr. Shishehbor was awarded the Carol and Arthur F. Anton Leadership Fellowship Program. He is a National Institutes of Health scholar and has won several awards from international and national organizations, including the prestigious Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award, and in 2009 he was awarded the VIVA/LINC Young Leader’s Award in Vascular. Currently, he serves as chair of the Vascular Council for Society for Cardiovascular Angiography and Interventions (SCAI). He is a writing member for ACC/AHA/SVM/SCAI/SVS/SIR/ACR Guidelines for Lower Extremity Peripheral Artery Disease. Dr. Shishehbor is also an active board member of the Cleveland Chapter of the American Heart Association where he is a voice for the community and proactively helps to provide solutions to a growing need. He has participated in over 100 community programs across Northeast Ohio.

Optimizing PCI (O-PCI) is a series of educational meetings dedicated to helping cardiologists optimize decision-making in interventional cardiac procedures using state-of-the-art intravascular imaging and physiology technologies.

Our renowned international faculty is committed to helping cardiologists master the interpretation of invasive diagnostic devices and treat them with precision, thus improving optimal patient outcomes.